
EXPLORATION OF PLANT BIOACTIVE FROM CASSIA FISTULA LEAVES FOR THE TREATMENT OF OVARIAN CANCER: AN INTEGRATIVE APPROACH
Author(s) -
K. Ramanathan,
Shanthi,
Kanika Verma
Publication year - 2016
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2016.v9i5.13187
Subject(s) - paclitaxel , cassia , in silico , ovarian cancer , in vivo , docking (animal) , tubulin , computational biology , pharmacology , chemistry , cancer , biology , medicine , biochemistry , microbiology and biotechnology , microtubule , gene , genetics , pathology , alternative medicine , nursing , traditional chinese medicine
Objective: Paclitaxel is one of the most effective anticancer agents. It is used as a chemotherapy agent for a spectrum of cancer types. However,paclitaxel resistance is one of the foremost problems for chemotherapy. Most importantly, an emergence of paclitaxel resistance due to mutation(F270V) in β-tubulin has been extremely deliberated in recent years. With the rise of paclitaxel-resistant mutation in β-tubulin, there is a need to adda novel inhibitor from natural source, as they have less chance of getting resistance additionally less side effects. Keeping this in mind, we have utilizedexperimental and in silico approaches to isolate the potent inhibitor for β-tubulin target protein.Methods: We have extracted phytocompounds from Cassia fistula plant, and the structures were recognized with the help of gas chromatographymassspectrometrytechnique.Subsequently,oralbioavailabilityandtoxicityanalysiswereexecutedfortheextractedcompoundsbyemployingMOLINSPIRATIONand OSIRIS program,respectively.Furthermore,docking analysiswasperformedusingYASARAalgorithm.Inaddition,bioactivityanalysisforthe screenedcompounds wasperformedusing predictionof activityspectraforsubstances program.Results: The results from our analysis clearly depict that HOP-22(29)-EN-3.BETA.-OL could be a promising inhibitor for the treatment of cancer andprovide direction for future research. Further in vitro and in vivo exploration is also required to identify whether HOP-22(29)-EN-3.BETA.-OL haveanticancer effect or not.Conclusion: The combination of computational approach and experimental analysis provides an easy approach to identify novel candidate for thetarget protein β-tubulin.Keywords: Phytochemicals, Gas chromatography mass spectrometry, Bioavailability, Molecular docking, Prediction of activity spectra for substancesprediction.